Authors
Loading...
Randomized trial shows TyG-ABSI predicts cardiovascular disease and mortality in hypertensive patients, suggesting improved risk assessment.
Su et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: